Summary
- Current Price
- As of today, DOCS price is $21.40, up +1.57% on
- Current Price All-Time High
- DOCS price is currently -80.15% below its historical high of $107.79 set on
- Market Cap
- DOCS current market cap is $4B, down -59.89% year-over-year
- PE Ratio
- DOCS current PE ratio is 21.81
- Revenue
- DOCS current annual revenue is $644.86M, up +13.05% year-over-year
- Next Earnings
- The next earnings release for DOCS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Doximity, Inc. |
| Ticker | NYSE: DOCS |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Health Information Services |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | doximity.com |
| Employees | 830 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $21.40 | |
| Price, 1D Change | +1.57% | |
| Market Cap | $4B | |
| - | ||
| PE Ratio | 21.81 | |
| Beta | 0.82 | |
| Revenue | $645M | |
| Revenue, 1Y Change | +13.05% | |
| EPS | $0.98 | |
| EPS, 1Y Change | -11.21% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $0.98 | |
| EPS Estimate | N/A | $1.43 |
| EPS Est. Change | N/A | +45.49% |
| Revenue | $644.86M | |
| Revenue Estimate | N/A | $670.48M |
| Revenue Est. Change | N/A | +3.97% |
| Current Price | $21.40 | |
| Price Target | - | $24.00 |
| Price Tgt. Change | - | +12.15% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.31 | $1.11 | -15.32% | |
| $1.55 | $0.98 | -36.32% | |
| $1.43 | N/A | +45.49% | |
| $1.59 | N/A | +61.90% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $569.54M | $570.40M | +0.15% | |
| $643.55M | $644.86M | +0.20% | |
| $670.48M | N/A | +3.97% | |
| $712.67M | N/A | +10.51% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -58.80% | |
| Price, 3Y | -30.32% | |
| Market Cap, 1Y | -59.89% | |
| Market Cap, 3Y | -34.54% | |
| Revenue, 1Y | +13.05% | |
| Revenue, 3Y | +53.89% | |
| EPS, 1Y | -11.21% | |
| EPS, 3Y | +86.32% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $21.40 | |
| SMA 200 | $43.95 | |
| SMA 200 vs Price | +105.38% | |
| SMA 50 | $23.11 | |
| SMA 50 vs Price | +7.98% | |
| Beta | 0.82 | |
| ATR | $1.29 | |
| 14-Day RSI | 46.49 | |
| 10-Day Volatility | 44.46% | |
| 1-Year Volatility | 54.32% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $644.86M | |
| EPS | $0.98 | |
| Gross Profit | $568.97M | |
| Gross Margin | 88.23% | |
| Operating Profit | $221.81M | |
| Operating Margin | 34.40% | |
| Net Income | $196.05M | |
| Net Margin | 30.40% | |
| EBITDA | $236.19M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.01 | |
| 6.04 | ||
| 6.04 | ||
| - | ||
| 7 | ||
| 14.96 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 21.81 | |
| 6.07 | ||
| 4.12 | ||
| 13.47 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $950.84M | |
| $748.60M | ||
| $1.13B | ||
| $936.26M | ||
| $180.98M | ||
| $154.97M | ||
| Total Debt | $10.19M | |
| $2.11M | ||
| $4.01M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $448.81M | ||
| $347.16M | ||
| $75.90M | ||
| $0.00 | ||
| $14.38M | ||
| $0.00 | ||
| $53.95M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $326.46M | ||
| $147.17M | ||
| -$464.06M | ||
| Capex | $8.96M | |
| $317.50M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Goldman Sachs | → | |
| Barclays | → | |
| Wells Fargo | → | |
| Truist Securities | → | |
| Needham | → | |
| Morgan Stanley | → | |
| Mizuho | → | |
| Leerink Partners | → | |
| Keybanc | → | |
| JP Morgan | → |
Analyst sentiment
Institutional ownership
Screeners with DOCS
FAQ
What is the ticker symbol for Doximity, Inc.?
The ticker symbol for Doximity, Inc. is NYSE:DOCS
Does Doximity, Inc. pay dividends?
No, Doximity, Inc. does not pay dividends
What sector is Doximity, Inc. in?
Doximity, Inc. is in the Healthcare sector
What industry is Doximity, Inc. in?
Doximity, Inc. is in the Health Information Services industry
What country is Doximity, Inc. based in?
Doximity, Inc. is headquartered in United States
When did Doximity, Inc. go public?
Doximity, Inc. initial public offering (IPO) was on June 24, 2021
Is Doximity, Inc. in the S&P 500?
No, Doximity, Inc. is not included in the S&P 500 index
Is Doximity, Inc. in the NASDAQ 100?
No, Doximity, Inc. is not included in the NASDAQ 100 index
Is Doximity, Inc. in the Dow Jones?
No, Doximity, Inc. is not included in the Dow Jones index
When was Doximity, Inc. last earnings report?
Doximity, Inc.'s most recent earnings report was on May 13, 2026
When does Doximity, Inc. report earnings?
The next expected earnings date for Doximity, Inc. is August 6, 2026
Data Sources & References
- DOCS Official Website www.doximity.com
- DOCS Profile on Yahoo Finance finance.yahoo.com/quote/DOCS
- DOCS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/docs